Connect with us

Health & Medicine

Breaking the Hallucinogenic Barrier: Researchers Develop LSD Analogue for Treating Schizophrenia

Researchers have developed a new, neuroplasticity-promoting drug closely related to LSD that harnesses the psychedelic’s therapeutic power with reduced hallucinogenic potential.

Avatar photo

Published

on

The article has been rewritten to improve clarity, structure, and style while maintaining the core ideas for a general audience.

Breaking the Hallucinogenic Barrier: Researchers Develop LSD Analogue for Treating Schizophrenia

Researchers at the University of California, Davis have made a groundbreaking discovery in developing a new drug closely related to LSD. The innovative compound, dubbed JRT, has been designed to harness the therapeutic potential of LSD while minimizing its hallucinogenic effects.

JRT’s development is significant as it may provide a much-needed treatment option for conditions like schizophrenia, where psychedelics are not prescribed due to safety concerns. The research, published in Proceedings of the National Academy of Sciences, highlights JRT’s potential as a treatment for other neuropsychiatric and neurodegenerative diseases characterized by synaptic loss and brain atrophy.

To design JRT, researchers simply flipped the position of two atoms in LSD’s molecular structure. This subtle modification resulted in a significant improvement in JRT’s selectivity profile and reduced its hallucinogenic potential while maintaining its neurotherapeutic properties.

The JRT molecule was named after Jeremy R. Tuck, a former graduate student who synthesized it, and is a testament to the innovative spirit of researchers. David E. Olson, corresponding author and director of the Institute for Psychedelics and Neurotherapeutics at UC Davis, explained that “what we did here is a tire rotation.” By modifying LSD in this way, JRT’s therapeutic potential was unlocked while minimizing its hallucinogenic effects.

JRT exhibited powerful neuroplastic effects and improved measures in mice relevant to the negative and cognitive symptoms of schizophrenia. Importantly, it did not exacerbate behaviors and gene expression associated with psychosis. This makes JRT a promising treatment option for patients where psychedelic use is precluded.

Olson emphasized that JRT’s development emphasizes the potential for using psychedelics as starting points to create better medicines. “We may be able to create medications that can be used in patient populations where psychedelic use is precluded,” he stated.

The researchers conducted a battery of cellular and mouse assays, which demonstrated JRT’s neuroplastic effects and improved safety profile relative to LSD. Key findings included:

* JRT has extremely high therapeutic potential.
* The molecule was tested in other disease models, improving its synthesis, and creating new analogues of JRT that might be even better.

JRT’s potential for treating schizophrenia is significant as most current treatments have limited effects on anhedonia – the inability to feel pleasure – and cognitive function. Clozapine is one exception but has side effects and is not a first-line drug of choice for people severely afflicted with schizophrenia.

Olson and his team are currently testing JRT’s potential against other neurodegenerative and neuropsychiatric diseases, paving the way for further research and development in this area.

Child Development

Music Therapy Breakthrough for Brain-Injured Children: A New Tool for Assessing Consciousness

Music could provide a breakthrough in assessing consciousness levels in children who have suffered significant brain injuries, according to new research.

Avatar photo

Published

on

The article has been rewritten to improve clarity, structure, and style, making it understandable to the general public. Here is the rewritten content:

Music therapy has long been used to help people recover from physical and emotional trauma, but now it may also be a breakthrough in assessing consciousness levels in children who have suffered significant brain injuries. Researchers at Anglia Ruskin University, The Children’s Trust, and Temple University have developed a new tool called MuSICCA (Music therapy Sensory Instrument for Cognition, Consciousness, and Awareness) to help doctors and caregivers determine the level of consciousness in children aged 2-18.

Currently, there is a lack of tools to assess consciousness in children, making it difficult for medical staff to provide proper care. As children grow and develop, their brains undergo significant changes that can make it even harder to determine their level of awareness. MuSICCA aims to change this by using specially selected music to stimulate the patient and encourage them to respond.

A qualified music therapist performs live music stimulation for the patient, manipulating different aspects of the music depending on how they respond. The music therapist observes the child’s behaviors and records these observations against a set of scales, which then produces a diagnosis of the level of consciousness.

In a recent study, researchers invited participants including music therapists, family members of children affected by brain injuries, and healthcare professionals to evaluate MuSICCA. The results were overwhelmingly positive, with 85% of participants strongly agreeing that MuSICCA is an assessment of consciousness and awareness, and 85% also strongly agreeing that it is suitable for use with children and young people.

The lead author of the study, Dr. Jonathan Pool, said: “Children with disorders of consciousness are often almost completely dependent on others to meet their needs. Their therapists, nurses, and caregivers must interpret very subtle behaviors to help them understand their needs. MuSICCA allows us to conduct a rigorous assessment of the patient’s response to various musical stimuli, giving us a picture of their level of consciousness and the strengths and weaknesses of their responses.”

The researchers believe that MuSICCA has the potential to revolutionize the way we assess consciousness in children with brain injuries, providing a more accurate and reliable method for doctors and caregivers to determine the best course of treatment.

Continue Reading

Cell Biology

Unlocking the Secrets of Deadly Tropical Diseases: A New Target for Treatment

The efforts of a research team give hope for new treatment approaches for dangerous tropical diseases. The researchers have compiled a high-precision inventory of the membrane proteins of cell organelles of the African sleeping sickness pathogen.

Avatar photo

Published

on

The fight against deadly tropical diseases has taken a significant step forward with the discovery of a promising target for new treatments. Researchers from Bochum and Würzburg have made a groundbreaking find in their study on the African sleeping sickness pathogen Trypanosoma brucei, which also causes Chagas disease and leishmaniasis.

In a breakthrough study published in Cell Reports, the researchers compiled a high-precision inventory of the membrane proteins of the glycosomes, unique cell organelles essential for the survival of the parasites. “Some of these proteins contain components that are specific to parasites and differ significantly from those of the host cells,” explains Professor Ralf Erdmann.

The team’s success in identifying 28 glycosome membrane proteins with a high degree of reliability opens up new avenues for targeted treatment strategies against these poorly understood tropical diseases. A particular highlight was the discovery of TbPEX15, a membrane anchor for an essential protein import complex that differs significantly from its counterpart in humans.

This finding provides a valuable resource for biomedical research into glycosome biology and deepens our understanding of parasite biology. The researchers’ work gives hope for new treatment approaches for diseases that affect over 12 million people worldwide.

The study’s findings are a significant step forward in the fight against deadly tropical diseases, and further research could lead to the development of new therapies and treatments.

Continue Reading

Cholesterol

The Hidden Dangers of Ultra-Processed Foods: A Risk Factor for Your Health?

Consumption of ultra-processed foods, such as sugar-sweetened beverages, potato chips and packaged cookies, may be associated with adverse health outcomes. Study finds each additional 100 grams/day consumption of ultra-processed foods increased risk of hypertension, cardiovascular events, cancer and more.

Avatar photo

Published

on

The consumption of ultra-processed foods has been linked to various adverse health outcomes, including hypertension, cardiovascular events, cancer, digestive diseases, and mortality. Research presented at the ACC Asia 2025 Together with SCS 36th Annual Scientific Meeting suggests that for every 100 grams of ultra-processed food consumed daily, the risk for these health issues increases.

Ultra-processed foods are characterized by high sugar, salt, and non-nutritive components, exhibiting low nutritional density yet high caloric content. These products may contribute to adverse health outcomes through mechanisms such as dysregulation of blood lipid profiles, alterations in gut microbiota composition, promotion of obesity, induction of systemic inflammation, exacerbation of oxidative stress, and impairment of insulin sensitivity.

A systematic review of 41 prospective cohort studies, spanning the Americas, Europe, Asia, and Oceania, found that ultra-processed food consumption was associated with increased risks for:

* Hypertension: 14.5% higher risk per 100g/day consumed
* Cardiovascular events: 5.9% higher risk per 100g/day consumed
* Cancer: 1.2% higher risk per 100g/day consumed
* Digestive diseases: 19.5% higher risk per 100g/day consumed
* All-cause mortality: 2.6% higher risk per 100g/day consumed

Researchers observed increased risks for obesity/overweight, metabolic syndromes/diabetes, and depression/anxiety.

The study’s findings suggest that clinicians should inform patients about the nutritional imbalance in ultra-processed foods and encourage them to reduce their consumption. Governments may consider implementing measures to mitigate the associated health impacts, such as establishing stringent food labeling regulations and requiring manufacturers to provide explicit ingredient disclosures.

Emerging evidence has linked health benefits to whole foods, simple ingredients, and culturally appropriate healthy eating patterns like the Mediterranean or DASH diet. Further high-quality studies on this topic are needed to inform public health recommendations and promote healthier eating habits.

Continue Reading

Trending